Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
This report aims to provide a comprehensive presentation of the global market for Somatostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatostatin. This report contains market size and forecasts of Somatostatin in global, including the following market information:
Global Somatostatin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Somatostatin Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Somatostatin companies in 2022 (%)
The global Somatostatin market was valued at US$ 346.3 million in 2022 and is projected to reach US$ 715 million by 2029, at a CAGR of 10.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
We surveyed the Somatostatin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Somatostatin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, by Type, 2022 (%)
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Global Somatostatin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, by Application, 2022 (%)
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Global Somatostatin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Somatostatin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Somatostatin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Somatostatin revenues share in global market, 2022 (%)
Key companies Somatostatin sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Somatostatin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Somatostatin, market overview.
Chapter 2: Global Somatostatin market size in revenue and volume.
Chapter 3: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Somatostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Somatostatin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Somatostatin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Somatostatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Somatostatin Overall Market Size
2.1 Global Somatostatin Market Size: 2022 VS 2029
2.2 Global Somatostatin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Somatostatin Sales: 2018-2029
3 Company Landscape
3.1 Top Somatostatin Players in Global Market
3.2 Top Global Somatostatin Companies Ranked by Revenue
3.3 Global Somatostatin Revenue by Companies
3.4 Global Somatostatin Sales by Companies
3.5 Global Somatostatin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Somatostatin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Somatostatin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Somatostatin Players in Global Market
3.8.1 List of Global Tier 1 Somatostatin Companies
3.8.2 List of Global Tier 2 and Tier 3 Somatostatin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Somatostatin Market Size Markets, 2022 & 2029
4.1.2 0.25mg/pcs
4.1.3 0.75mg/pcs
4.1.4 3mg/pcs
4.2 By Type - Global Somatostatin Revenue & Forecasts
4.2.1 By Type - Global Somatostatin Revenue, 2018-2023
4.2.2 By Type - Global Somatostatin Revenue, 2024-2029
4.2.3 By Type - Global Somatostatin Revenue Market Share, 2018-2029
4.3 By Type - Global Somatostatin Sales & Forecasts
4.3.1 By Type - Global Somatostatin Sales, 2018-2023
4.3.2 By Type - Global Somatostatin Sales, 2024-2029
4.3.3 By Type - Global Somatostatin Sales Market Share, 2018-2029
4.4 By Type - Global Somatostatin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Somatostatin Market Size, 2022 & 2029
5.1.2 Hormonal Disorder
5.1.3 Oncology
5.1.4 Metabolic Disorder
5.1.5 Others
5.2 By Application - Global Somatostatin Revenue & Forecasts
5.2.1 By Application - Global Somatostatin Revenue, 2018-2023
5.2.2 By Application - Global Somatostatin Revenue, 2024-2029
5.2.3 By Application - Global Somatostatin Revenue Market Share, 2018-2029
5.3 By Application - Global Somatostatin Sales & Forecasts
5.3.1 By Application - Global Somatostatin Sales, 2018-2023
5.3.2 By Application - Global Somatostatin Sales, 2024-2029
5.3.3 By Application - Global Somatostatin Sales Market Share, 2018-2029
5.4 By Application - Global Somatostatin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Somatostatin Market Size, 2022 & 2029
6.2 By Region - Global Somatostatin Revenue & Forecasts
6.2.1 By Region - Global Somatostatin Revenue, 2018-2023
6.2.2 By Region - Global Somatostatin Revenue, 2024-2029
6.2.3 By Region - Global Somatostatin Revenue Market Share, 2018-2029
6.3 By Region - Global Somatostatin Sales & Forecasts
6.3.1 By Region - Global Somatostatin Sales, 2018-2023
6.3.2 By Region - Global Somatostatin Sales, 2024-2029
6.3.3 By Region - Global Somatostatin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Somatostatin Revenue, 2018-2029
6.4.2 By Country - North America Somatostatin Sales, 2018-2029
6.4.3 US Somatostatin Market Size, 2018-2029
6.4.4 Canada Somatostatin Market Size, 2018-2029
6.4.5 Mexico Somatostatin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Somatostatin Revenue, 2018-2029
6.5.2 By Country - Europe Somatostatin Sales, 2018-2029
6.5.3 Germany Somatostatin Market Size, 2018-2029
6.5.4 France Somatostatin Market Size, 2018-2029
6.5.5 U.K. Somatostatin Market Size, 2018-2029
6.5.6 Italy Somatostatin Market Size, 2018-2029
6.5.7 Russia Somatostatin Market Size, 2018-2029
6.5.8 Nordic Countries Somatostatin Market Size, 2018-2029
6.5.9 Benelux Somatostatin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Somatostatin Revenue, 2018-2029
6.6.2 By Region - Asia Somatostatin Sales, 2018-2029
6.6.3 China Somatostatin Market Size, 2018-2029
6.6.4 Japan Somatostatin Market Size, 2018-2029
6.6.5 South Korea Somatostatin Market Size, 2018-2029
6.6.6 Southeast Asia Somatostatin Market Size, 2018-2029
6.6.7 India Somatostatin Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Somatostatin Revenue, 2018-2029
6.7.2 By Country - South America Somatostatin Sales, 2018-2029
6.7.3 Brazil Somatostatin Market Size, 2018-2029
6.7.4 Argentina Somatostatin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Somatostatin Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Somatostatin Sales, 2018-2029
6.8.3 Turkey Somatostatin Market Size, 2018-2029
6.8.4 Israel Somatostatin Market Size, 2018-2029
6.8.5 Saudi Arabia Somatostatin Market Size, 2018-2029
6.8.6 UAE Somatostatin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck (Schweiz) AG
7.1.1 Merck (Schweiz) AG Company Summary
7.1.2 Merck (Schweiz) AG Business Overview
7.1.3 Merck (Schweiz) AG Somatostatin Major Product Offerings
7.1.4 Merck (Schweiz) AG Somatostatin Sales and Revenue in Global (2018-2023)
7.1.5 Merck (Schweiz) AG Key News & Latest Developments
7.2 SANOFI-AVENTIS FRANCE
7.2.1 SANOFI-AVENTIS FRANCE Company Summary
7.2.2 SANOFI-AVENTIS FRANCE Business Overview
7.2.3 SANOFI-AVENTIS FRANCE Somatostatin Major Product Offerings
7.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales and Revenue in Global (2018-2023)
7.2.5 SANOFI-AVENTIS FRANCE Key News & Latest Developments
7.3 Lyomark Pharma GmbH
7.3.1 Lyomark Pharma GmbH Company Summary
7.3.2 Lyomark Pharma GmbH Business Overview
7.3.3 Lyomark Pharma GmbH Somatostatin Major Product Offerings
7.3.4 Lyomark Pharma GmbH Somatostatin Sales and Revenue in Global (2018-2023)
7.3.5 Lyomark Pharma GmbH Key News & Latest Developments
7.4 ALFA WASSERMANN S.p.A.
7.4.1 ALFA WASSERMANN S.p.A. Company Summary
7.4.2 ALFA WASSERMANN S.p.A. Business Overview
7.4.3 ALFA WASSERMANN S.p.A. Somatostatin Major Product Offerings
7.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales and Revenue in Global (2018-2023)
7.4.5 ALFA WASSERMANN S.p.A. Key News & Latest Developments
7.5 Polypeptide Laboratories, Inc
7.5.1 Polypeptide Laboratories, Inc Company Summary
7.5.2 Polypeptide Laboratories, Inc Business Overview
7.5.3 Polypeptide Laboratories, Inc Somatostatin Major Product Offerings
7.5.4 Polypeptide Laboratories, Inc Somatostatin Sales and Revenue in Global (2018-2023)
7.5.5 Polypeptide Laboratories, Inc Key News & Latest Developments
7.6 SAMARTH
7.6.1 SAMARTH Company Summary
7.6.2 SAMARTH Business Overview
7.6.3 SAMARTH Somatostatin Major Product Offerings
7.6.4 SAMARTH Somatostatin Sales and Revenue in Global (2018-2023)
7.6.5 SAMARTH Key News & Latest Developments
7.7 UBPL
7.7.1 UBPL Company Summary
7.7.2 UBPL Business Overview
7.7.3 UBPL Somatostatin Major Product Offerings
7.7.4 UBPL Somatostatin Sales and Revenue in Global (2018-2023)
7.7.5 UBPL Key News & Latest Developments
7.8 HYBIO
7.8.1 HYBIO Company Summary
7.8.2 HYBIO Business Overview
7.8.3 HYBIO Somatostatin Major Product Offerings
7.8.4 HYBIO Somatostatin Sales and Revenue in Global (2018-2023)
7.8.5 HYBIO Key News & Latest Developments
7.9 TianTaiShan
7.9.1 TianTaiShan Company Summary
7.9.2 TianTaiShan Business Overview
7.9.3 TianTaiShan Somatostatin Major Product Offerings
7.9.4 TianTaiShan Somatostatin Sales and Revenue in Global (2018-2023)
7.9.5 TianTaiShan Key News & Latest Developments
7.10 Yangtze River
7.10.1 Yangtze River Company Summary
7.10.2 Yangtze River Business Overview
7.10.3 Yangtze River Somatostatin Major Product Offerings
7.10.4 Yangtze River Somatostatin Sales and Revenue in Global (2018-2023)
7.10.5 Yangtze River Key News & Latest Developments
7.11 Siyao
7.11.1 Siyao Company Summary
7.11.2 Siyao Somatostatin Business Overview
7.11.3 Siyao Somatostatin Major Product Offerings
7.11.4 Siyao Somatostatin Sales and Revenue in Global (2018-2023)
7.11.5 Siyao Key News & Latest Developments
7.12 Shuangcheng
7.12.1 Shuangcheng Company Summary
7.12.2 Shuangcheng Somatostatin Business Overview
7.12.3 Shuangcheng Somatostatin Major Product Offerings
7.12.4 Shuangcheng Somatostatin Sales and Revenue in Global (2018-2023)
7.12.5 Shuangcheng Key News & Latest Developments
7.13 Hainan Zhonghe
7.13.1 Hainan Zhonghe Company Summary
7.13.2 Hainan Zhonghe Somatostatin Business Overview
7.13.3 Hainan Zhonghe Somatostatin Major Product Offerings
7.13.4 Hainan Zhonghe Somatostatin Sales and Revenue in Global (2018-2023)
7.13.5 Hainan Zhonghe Key News & Latest Developments
7.14 SL PHARM
7.14.1 SL PHARM Company Summary
7.14.2 SL PHARM Business Overview
7.14.3 SL PHARM Somatostatin Major Product Offerings
7.14.4 SL PHARM Somatostatin Sales and Revenue in Global (2018-2023)
7.14.5 SL PHARM Key News & Latest Developments
7.15 Wuhan Hualong
7.15.1 Wuhan Hualong Company Summary
7.15.2 Wuhan Hualong Business Overview
7.15.3 Wuhan Hualong Somatostatin Major Product Offerings
7.15.4 Wuhan Hualong Somatostatin Sales and Revenue in Global (2018-2023)
7.15.5 Wuhan Hualong Key News & Latest Developments
7.16 Qingdao Guoda
7.16.1 Qingdao Guoda Company Summary
7.16.2 Qingdao Guoda Business Overview
7.16.3 Qingdao Guoda Somatostatin Major Product Offerings
7.16.4 Qingdao Guoda Somatostatin Sales and Revenue in Global (2018-2023)
7.16.5 Qingdao Guoda Key News & Latest Developments
7.17 Chengdu Shengnuo
7.17.1 Chengdu Shengnuo Company Summary
7.17.2 Chengdu Shengnuo Business Overview
7.17.3 Chengdu Shengnuo Somatostatin Major Product Offerings
7.17.4 Chengdu Shengnuo Somatostatin Sales and Revenue in Global (2018-2023)
7.17.5 Chengdu Shengnuo Key News & Latest Developments
7.18 Longjin
7.18.1 Longjin Company Summary
7.18.2 Longjin Business Overview
7.18.3 Longjin Somatostatin Major Product Offerings
7.18.4 Longjin Somatostatin Sales and Revenue in Global (2018-2023)
7.18.5 Longjin Key News & Latest Developments
8 Global Somatostatin Production Capacity, Analysis
8.1 Global Somatostatin Production Capacity, 2018-2029
8.2 Somatostatin Production Capacity of Key Manufacturers in Global Market
8.3 Global Somatostatin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Somatostatin Supply Chain Analysis
10.1 Somatostatin Industry Value Chain
10.2 Somatostatin Upstream Market
10.3 Somatostatin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Somatostatin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Somatostatin in Global Market
Table 2. Top Somatostatin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Somatostatin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Somatostatin Revenue Share by Companies, 2018-2023
Table 5. Global Somatostatin Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Somatostatin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Somatostatin Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Somatostatin Product Type
Table 9. List of Global Tier 1 Somatostatin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Somatostatin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Somatostatin Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Somatostatin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Somatostatin Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Somatostatin Sales (K Pcs), 2018-2023
Table 15. By Type - Global Somatostatin Sales (K Pcs), 2024-2029
Table 16. By Application ? Global Somatostatin Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Somatostatin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Somatostatin Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Somatostatin Sales (K Pcs), 2018-2023
Table 20. By Application - Global Somatostatin Sales (K Pcs), 2024-2029
Table 21. By Region ? Global Somatostatin Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Somatostatin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Somatostatin Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Somatostatin Sales (K Pcs), 2018-2023
Table 25. By Region - Global Somatostatin Sales (K Pcs), 2024-2029
Table 26. By Country - North America Somatostatin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Somatostatin Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Somatostatin Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Somatostatin Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Somatostatin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Somatostatin Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Somatostatin Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Somatostatin Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Somatostatin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Somatostatin Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Somatostatin Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Somatostatin Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Somatostatin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Somatostatin Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Somatostatin Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Somatostatin Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Somatostatin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Somatostatin Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Somatostatin Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Somatostatin Sales, (K Pcs), 2024-2029
Table 46. Merck (Schweiz) AG Company Summary
Table 47. Merck (Schweiz) AG Somatostatin Product Offerings
Table 48. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Merck (Schweiz) AG Key News & Latest Developments
Table 50. SANOFI-AVENTIS FRANCE Company Summary
Table 51. SANOFI-AVENTIS FRANCE Somatostatin Product Offerings
Table 52. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. SANOFI-AVENTIS FRANCE Key News & Latest Developments
Table 54. Lyomark Pharma GmbH Company Summary
Table 55. Lyomark Pharma GmbH Somatostatin Product Offerings
Table 56. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Lyomark Pharma GmbH Key News & Latest Developments
Table 58. ALFA WASSERMANN S.p.A. Company Summary
Table 59. ALFA WASSERMANN S.p.A. Somatostatin Product Offerings
Table 60. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. ALFA WASSERMANN S.p.A. Key News & Latest Developments
Table 62. Polypeptide Laboratories, Inc Company Summary
Table 63. Polypeptide Laboratories, Inc Somatostatin Product Offerings
Table 64. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Polypeptide Laboratories, Inc Key News & Latest Developments
Table 66. SAMARTH Company Summary
Table 67. SAMARTH Somatostatin Product Offerings
Table 68. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. SAMARTH Key News & Latest Developments
Table 70. UBPL Company Summary
Table 71. UBPL Somatostatin Product Offerings
Table 72. UBPL Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. UBPL Key News & Latest Developments
Table 74. HYBIO Company Summary
Table 75. HYBIO Somatostatin Product Offerings
Table 76. HYBIO Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. HYBIO Key News & Latest Developments
Table 78. TianTaiShan Company Summary
Table 79. TianTaiShan Somatostatin Product Offerings
Table 80. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. TianTaiShan Key News & Latest Developments
Table 82. Yangtze River Company Summary
Table 83. Yangtze River Somatostatin Product Offerings
Table 84. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Yangtze River Key News & Latest Developments
Table 86. Siyao Company Summary
Table 87. Siyao Somatostatin Product Offerings
Table 88. Siyao Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Siyao Key News & Latest Developments
Table 90. Shuangcheng Company Summary
Table 91. Shuangcheng Somatostatin Product Offerings
Table 92. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Shuangcheng Key News & Latest Developments
Table 94. Hainan Zhonghe Company Summary
Table 95. Hainan Zhonghe Somatostatin Product Offerings
Table 96. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Hainan Zhonghe Key News & Latest Developments
Table 98. SL PHARM Company Summary
Table 99. SL PHARM Somatostatin Product Offerings
Table 100. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. SL PHARM Key News & Latest Developments
Table 102. Wuhan Hualong Company Summary
Table 103. Wuhan Hualong Somatostatin Product Offerings
Table 104. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Wuhan Hualong Key News & Latest Developments
Table 106. Qingdao Guoda Company Summary
Table 107. Qingdao Guoda Somatostatin Product Offerings
Table 108. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Qingdao Guoda Key News & Latest Developments
Table 110. Chengdu Shengnuo Company Summary
Table 111. Chengdu Shengnuo Somatostatin Product Offerings
Table 112. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Chengdu Shengnuo Key News & Latest Developments
Table 114. Longjin Company Summary
Table 115. Longjin Somatostatin Product Offerings
Table 116. Longjin Somatostatin Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 117. Longjin Key News & Latest Developments
Table 118. Somatostatin Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 119. Global Somatostatin Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Somatostatin Production by Region, 2018-2023 (K Pcs)
Table 121. Global Somatostatin Production by Region, 2024-2029 (K Pcs)
Table 122. Somatostatin Market Opportunities & Trends in Global Market
Table 123. Somatostatin Market Drivers in Global Market
Table 124. Somatostatin Market Restraints in Global Market
Table 125. Somatostatin Raw Materials
Table 126. Somatostatin Raw Materials Suppliers in Global Market
Table 127. Typical Somatostatin Downstream
Table 128. Somatostatin Downstream Clients in Global Market
Table 129. Somatostatin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Somatostatin Segment by Type in 2022
Figure 2. Somatostatin Segment by Application in 2022
Figure 3. Global Somatostatin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Somatostatin Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Somatostatin Revenue, 2018-2029 (US$, Mn)
Figure 7. Somatostatin Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Somatostatin Revenue in 2022
Figure 9. By Type - Global Somatostatin Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Somatostatin Revenue Market Share, 2018-2029
Figure 11. By Type - Global Somatostatin Sales Market Share, 2018-2029
Figure 12. By Type - Global Somatostatin Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Somatostatin Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Somatostatin Revenue Market Share, 2018-2029
Figure 15. By Application - Global Somatostatin Sales Market Share, 2018-2029
Figure 16. By Application - Global Somatostatin Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Somatostatin Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Somatostatin Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Somatostatin Revenue Market Share, 2018-2029
Figure 20. By Region - Global Somatostatin Sales Market Share, 2018-2029
Figure 21. By Country - North America Somatostatin Revenue Market Share, 2018-2029
Figure 22. By Country - North America Somatostatin Sales Market Share, 2018-2029
Figure 23. US Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Somatostatin Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Somatostatin Sales Market Share, 2018-2029
Figure 28. Germany Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 29. France Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Somatostatin Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Somatostatin Sales Market Share, 2018-2029
Figure 37. China Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 41. India Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Somatostatin Revenue Market Share, 2018-2029
Figure 43. By Country - South America Somatostatin Sales Market Share, 2018-2029
Figure 44. Brazil Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Somatostatin Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Somatostatin Sales Market Share, 2018-2029
Figure 48. Turkey Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Somatostatin Revenue, (US$, Mn), 2018-2029
Figure 52. Global Somatostatin Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Somatostatin by Region, 2022 VS 2029
Figure 54. Somatostatin Industry Value Chain
Figure 55. Marketing Channels
